The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

ARID1a as a marker of prognosis and increased sensitivity to CDK4/6, mTOR 1/2 and Src homology region 2 phosphatase (SHP 1/2) inhibitors in breast cancer (BC).

Veronica  Mariotti

No Relationships to Disclose

Howard L.  McLeod

Leadership - Cancer Genetics

Stock and Other Ownership Interests  - Cancer Genetics; Interpares Biomedicine

Honoraria - Genentech/Roche; Illumina

Consulting or Advisory Role - Admera Health; Cancer Genetics; eviCore healthcare; Gentris; NIH/NCI; Pharmazam; Saladax Biomedical

Hatem Hussein  Soliman

Consulting or Advisory Role - AstraZeneca; Celgene; Lilly; Novartis; Pfizer

Research Funding - Amgen (Inst)

Travel, Accommodations, Expenses - AstraZeneca; Lilly